Related Experiment Videos
7TM receptors: the splicing on the cake.
G J Kilpatrick1, F M Dautzenberg, G R Martin
1Pre-clinical CNS Department, F. Hoffmann-La Roche, Basel 4070, Switzerland.
Trends in Pharmacological Sciences
|July 3, 1999
Summary
Alternative splicing of introns in seven transmembrane (7TM) receptors generates diverse receptor isoforms. This review examines alternatively spliced variants of hormone and neurotransmitter 7TM receptors, their physiological significance, and classification challenges.
Area of Science:
- Molecular Biology
- Pharmacology
- Genetics
Background:
- Functional diversity in seven transmembrane (7TM) receptors typically arises from multiple receptor subtypes encoded by distinct genes.
- Introns within 7TM receptor genes allow for alternative splicing, creating diverse messenger RNAs (mRNAs) and distinct receptor isoforms.
- A significant number of 7TM receptor splice variants have been identified.
Purpose of the Study:
- To review current data on alternatively spliced variants of hormone and neurotransmitter 7TM receptors.
- To consider the potential physiological importance of these splice variants.
- To address issues related to the classification and nomenclature of receptor isoforms generated by alternative splicing.
Main Methods:
- Literature review of existing studies on 7TM receptor splice variants.
- Analysis of data concerning hormone and neurotransmitter receptors.
- Discussion of physiological implications and classification challenges.
Main Results:
- Alternative splicing is a significant source of functional diversity in 7TM receptors, beyond gene duplication.
- Numerous alternatively spliced variants of hormone and neurotransmitter 7TM receptors have been identified.
- The physiological roles and precise classification of these isoforms require further investigation.
Conclusions:
- Alternative splicing significantly expands the functional repertoire of 7TM receptors.
- Understanding these splice variants is crucial for comprehending receptor signaling and developing targeted therapeutics.
- Standardized nomenclature is needed for accurately describing receptor isoforms arising from alternative splicing.